GlassScriptPhysician profile
Harleen Singh
NPI 1275968281
$1,119.13
in general payments reported to CMS, 2019-2025
17 companies · $51.24 in 2025
The $51.24 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2020: $307 · 2023: $46.77 · 2024: $18.76 · 2025: $51.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $315.43 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $138.51 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $111.65 | 2019-2020 | |
| Allergan, INC. | $107.16 | 2019-2020 | |
| Lundbeck LLC | $74.23 | 2020 | |
| Shire North American Group INC | $74.19 | 2019 | |
| Abbvie INC. | $61.43 | 2023-2025 | Vraylar, Qulipta |
| Vanda Pharmaceuticals INC. | $52.38 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $30.41 | 2020-2024 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $27.97 | 2019 | |
| Merck Sharp & Dohme LLC | $25.67 | 2019-2020 | |
| Boston Scientific Corporation | $22.21 | 2025 | Axonics |
| Jazz Pharmaceuticals INC. | $20.72 | 2019 | |
| Eisai INC. | $15.48 | 2020 | |
| Almatica Pharma LLC | $14.37 | 2025 | Loreev Xr |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neuronetics, INC. | $13.99 | 2019 | |
| Noven Therapeutics, LLC | $13.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harleen Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.